Stay updated on Combination Immunotherapy for Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Combination Immunotherapy for Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Immunotherapy for Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A funding/status notice and a revision tag were added to the page; related topics such as 'Prostate cancer' and 'MedlinePlus Genetics' were removed from the page.
    Difference
    0.5%
    Check dated 2026-02-04T10:36:51.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Glossary display is now enabled and the footer metadata was updated to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0, while the previous Last Update Submitted that met QC Criteria, No FEAR Act Data, and Revision: v3.3.4 were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:11:51.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4. Removed Prostate cancer, related topics: MedlinePlus Genetics, and Revision: v3.3.3.
    Difference
    0.2%
    Check dated 2026-01-14T03:39:00.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Added related topics to the study page: Prostate cancer and MedlinePlus Genetics; no deletions observed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-07T01:33:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Related topics links for Prostate cancer and MedlinePlus Genetics were removed. The primary study details, eligibility criteria, and outcomes remain unchanged.
    Difference
    0.1%
    Check dated 2025-12-30T22:33:52.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Added related topics Prostate cancer and MedlinePlus Genetics, and Maryland as a location. Removed HHS Vulnerability Disclosure and Maryland Locations, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:57:21.000Z thumbnail image

Stay in the know with updates to Combination Immunotherapy for Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy for Prostate Cancer Clinical Trial page.